Vidja Prakash J, Vachhani J H, Sheikh S S, Santwani P M
Department of Pathology, M.P.Shah Medical College, Jamnagar, 361008 Gujarat India.
Indian J Hematol Blood Transfus. 2011 Jun;27(2):65-9. doi: 10.1007/s12288-011-0057-3. Epub 2011 Apr 11.
Transfusion Transmitted Infection (TTI) continue to be a problem in many parts of world and multi-transfused patients of beta thalassaemia major are at a particularly increased risk of TTI. This study is aimed to estimate the prevalence of blood TTI in multiple blood transfused patients of beta thalassaemia major. Cross-sectional study of 200 multi-transfused patients of beta thalassaemia major, who were interviewed using a structured questionnaire and history was taken regarding sero-status of HIV (Human Immunodeficiency Virus), HBV (Hepatitis B Virus), HCV (Hepatitis C Virus) infection from their case papers. This study was conducted at the department of Pathology, M.P. Shah medical college, Jamnagar and Thalassemia ward, G.G. Hospital, Jamnagar (Gujarat, India) from March to May 2010. Out of 200 multiple blood transfused patients 7% patients were infected with TTI. Total 9 male patients and 5 female patients were infected with TTI. The seroreactivity for HIV was 3% (06/200); 1% (02/200) were males and 2% (04/200) were females. The seroreactivity for HBV was 2% (04/200) all were males. The seroreactivity for HCV was 2% (04/200); 1.5% (03/200) were males and 0.5% (01/200) was female. HIV, HBV, HCV infections are most prevalent TTI among multiple blood transfused patients of beta thalassemia major, and remains a major health problem for these patients.
输血传播感染(TTI)在世界许多地区仍然是一个问题,重型β地中海贫血的多次输血患者感染TTI的风险尤其增加。本研究旨在估计重型β地中海贫血多次输血患者中血液TTI的患病率。对200例重型β地中海贫血多次输血患者进行横断面研究,使用结构化问卷对他们进行访谈,并从他们的病历中获取关于HIV(人类免疫缺陷病毒)、HBV(乙型肝炎病毒)、HCV(丙型肝炎病毒)感染血清状态的病史。本研究于2010年3月至5月在贾姆讷格尔MP沙阿医学院病理学系和贾姆讷格尔GG医院地中海贫血病房(古吉拉特邦,印度)进行。在200例多次输血患者中,7%的患者感染了TTI。共有9例男性患者和5例女性患者感染了TTI。HIV的血清反应性为3%(6/200);男性为1%(2/200),女性为2%(4/200)。HBV的血清反应性为2%(4/200),均为男性。HCV的血清反应性为2%(4/200);男性为1.5%(3/200),女性为0.5%(1/200)。HIV、HBV、HCV感染是重型β地中海贫血多次输血患者中最常见的TTI类型,并且仍然是这些患者的一个主要健康问题。